Bespak Injectables launches to global pharmaceutical industries
Following its acquisition of The Medical House (TMH) in 2009, Consort Medical plc is pleased to announce the launch of Bespak Injectables, incorporating elements of the TMH and Bespak.
This new identity promotes to Bespak’s blue chip pharmaceutical customer base the unique combination of TMH’s autoinjector design and Bespak’s manufacturing capabilities. With a focus on creation of innovative self-injection systems based on its proprietary device platform technologies, TMH has been successful in partnering with pharmaceutical company customers in injector device development, licensing and supply deals. Now established within the Consort Medical group, Bespak Injectables offers a full technology and service capability, taking device development from concept through design for manufacture regulatory approval and into high volume manufacturing and supply. Bespak Injectables is well placed to secure new, long-term licensing and supply business in the growing market for self-injection devices.